Page last updated: 2024-10-26

doxapram and Hemorrhagic Shock

doxapram has been researched along with Hemorrhagic Shock in 2 studies

Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Winnie, AP1
Collins, VJ1
Franko, BV1
Ward, JW1
Gilbert, DL1

Other Studies

2 other studies available for doxapram and Hemorrhagic Shock

ArticleYear
Clinical management of the patient in shock. Pharmacologic adjuncts to the management of shock.
    Clinical anesthesia, 1965, Volume: 2

    Topics: Aged; Atropine; Central Nervous System Stimulants; Chlorpromazine; Dextrans; Doxapram; Female; Human

1965
Doxapram hydrochloride in hemorrhagic hypotension.
    Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1971, Volume: 137, Issue:1

    Topics: Animals; Blood Pressure; Central Nervous System Stimulants; Dogs; Doxapram; Female; Hypotension; Mal

1971